Antipsychotic Use for ICU Delirium and Associated Inflammatory Markers

Purpose: We sought to evaluate critically ill patients with delirium to evaluate inflammatory cytokine production and delirium progression and the role of antipsychotics. Materials and Methods: Adult critically ill patients with confirmed delirium according to a positive CAM-ICU score were included and IL-6 and IL-8 levels were trended for 24 h in this single-center, prospective, observational cohort study. Results: A total of 23 patients were consented and had blood samples drawn for inclusion. There was no difference in IL-6 and IL-8 levels at baseline, 4 to 8 h, and 22 to 28 h after enrollment when comparing patients based on antipsychotic exposure. We identified 2 patient clusters based on age, APACHE III, need for mechanical ventilation, and concomitant infection. In cluster 1, 5 (33.3%) patients received antipsychotics versus 5 (62.5%) patients in cluster 2 (P = .18). Patients in cluster 1 had more co-inflammatory conditions (P < .0001), yet numerically lower baseline IL-6 (P = .18) and IL-8 levels (P = .80) compared to cluster 2. Patients in cluster 1 had a greater median number of delirium-free days compared to cluster 2 (17.0 vs 6.0 days; P = .05). Conclusions: In critically ill patients with delirium, IL-6 and IL-8 levels were variable and antipsychotics were not associated with improvements in delirium or inflammatory markers.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:39

Enthalten in:

Journal of intensive care medicine - 39(2024), 4 vom: 01. Apr., Seite 313-319

Sprache:

Englisch

Beteiligte Personen:

Torbic, Heather [VerfasserIn]
Chen, Alyssa [VerfasserIn]
Lumpkin, Mollie [VerfasserIn]
Yerke, Jason [VerfasserIn]
Mehkri, Omar [VerfasserIn]
Abraham, Susamma [VerfasserIn]
Wang, Xiaofeng [VerfasserIn]
Duggal, Abhijit [VerfasserIn]
Scheraga, Rachel G [VerfasserIn]

Links:

Volltext

Themen:

Antipsychotic
Antipsychotic Agents
Critically ill
Delirium
Inflammatory marker
Interleukin
Interleukin-6
Interleukin-8
Journal Article
Observational Study

Anmerkungen:

Date Completed 21.02.2024

Date Revised 02.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1177/08850666231201567

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM362208468